Clip procedure to repair leaking tricuspid valve
Part of Heart & circulation clinical trials.
This trial studies whether a heart procedure called K-Clip TM helps people with severe “secondary” tricuspid valve leakage who are at high risk for open-heart surgery. It aims to improve symptoms and valve function using a less-invasive, catheter-based repair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 60 or older (man or woman).
- You have severe or worse secondary tricuspid regurgitation (leaking), and you have symptoms like shortness of breath, leg swelling, or fluid in the belly.
- Your heart strength is still reduced but not too low (left ventricle ejection fraction is 40% or higher).
- You’ve had the best usual medicines for tricuspid leakage for at least 30 days and your symptoms have been stable.
- Your valve leak causes limitations in daily life (NYHA heart-failure class 2 to 4).
- A heart team agrees you are high risk for surgery and the clip procedure is expected to help, and you (or your guardian) sign informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.
This study tests a device called TriClip to repair a leaky tricuspid valve in the heart. If the leak is reduced, you may have less shortness of breath and feel more energetic.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This study is testing whether the TriClip device helps people with severe tricuspid regurgitation (a leaky heart valve) feel better. It compares people who received the TriClip to those who didn't get the procedure.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.